◆ 会议时间：2022年3月6日至9日
◆ 会议地点：美国 休斯顿/Houston, Texas, U. S. A.
◆ 会议简介：
2022年第14届国际胃癌大会(IGCC 2022)将于2022年3月6日至9日在美国德克萨斯州休斯顿以线上+线下混合会议形式举行。IGCC是国际胃癌协会 (IGCA)主办的两年一届的全球性会议，会议主题涵盖胃癌的基础和转化研究、预防、诊断（含早诊和筛查）、治疗、康复宣等各个方面。
国际胃癌协会(IGCA)成立于1995年3月29日，其宗旨是为推进胃癌的预防、诊断和治疗研究提供一个国际论坛；促进全世界胃癌的根除。未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）.
INTERNATIONAL GASTRIC CANCER CONGRESS 2022 | HYBRID | MARCH 6 - 9, 2022
THE EVOLUTION OF GASTRIC CANCER SCIENCE;
THE FUTURE OF GASTRIC CANCER TREATMENT
GENERAL INFORMATION & DEADLINES
- Abstracts are to be submitted electronically via online submission system by 18 October 2021.
Abstracts received after the deadline will not be accepted and therefore will not be considered for the program.
- Authors may submit more than one abstract, but, subject to program space, not all abstracts may be accepted.
- During the submission a preferred presentation type must be selected for each submitted abstract. Please note the Congress Scientific Committee reserves the right to make the final determination regarding the presentation format of accepted abstracts.
- Encore abstracts will be accepted.
- There are two separate submission platforms for a) Oral or Poster Presentation Abstract Submission or b) Video Presentation Abstract Submission. All individual submissions must fulfil the requirements (see Abstract Requirements below). Each author needs to select the submission platform first when logged into his/her Congress Portal account and only then can proceed with the submission itself. When submitting Oral or Poster Presentation Abstract, authors may select Oral or Poster, or Poster only.
- Authors of all accepted abstracts are expected to register for IGCC 2022 and pay the meeting registration fee and are encouraged to pay their IGCA dues.
- Abstracts can be amended in the online submission system until the submission deadline 18 October 2021.
- All successfully submitted abstracts will be reviewed by the IGCC 2022 Scientific Committee, who will consider its formal aspects and the content and may reconsider the pre-selected presentation type.
- All accepted abstracts will form part of the final scientific program and will be presented onsite as well as published in the official congress proceedings and congress app/website.
- All presenting authors will receive an acceptance/rejection notification via e-mail in late November.
- All presenting authors are obliged to register by 15 December, 2021. Those presenting authors who will not be registered for the Congress and whose registration will not be fully covered by the deadline will be automatically withdrawn from the final program.
- Abstract authors are also required to provide Institutional Review Board (IRB) approval (if applicable) and disclosure of financial relationships during the submission (e.g. grants, fees from private companies, shares, paid positions).
When submitting your abstract, consider and choose the corresponding scientific topic.
- Genetics and translational research
- Pathology, biomarkers, liquid biopsy, molecular classification
- Prevention and early detection
- Diagnosis and staging
- Endoscopic treatment
- Surgery and quality assurance
- Minimally-invasive and robot-assisted surgery
- Multidisciplinary treatment of localized gastric cancer
- Treatment and surgery for GEJ tumors
- Management of stage IV gastric cancer, peritoneal targeted therapy
- Novel drugs, targeted therapy, and immunotherapy
- Economic burden of GC and treatment in different healthcare systems
- Survivorship, Supportive and Palliative care, Nutrition, Quality-of-life
- Gastric cancer treatment during COVID-19 pandemic
- Artificial intelligence in gastric cancer diagnosis/treatment
- Surgery Videos (Video Presentation Abstract)
- Endoscopy videos (Video Presentation Abstract)
The International Gastric Cancer Association (IGCA) is pleased to invite you to Houston, Texas, to join us for the International Gastric Cancer Congress held from 6-9 March 2022. IGCC 2022 will provide a forum for exchange on cutting-edge scientific and clinical information. The congress will draw on speakers from around the globe to provide world-class research, scientific, and medical content for our attendees.
Attendees can look forward to themes and topics which will highlight the evolution of gastric cancer science and the future of gastric cancer treatment. The IGCC 2022 congress theme will be reflected through the scientific program in a series of high-profile plenary presentations, patient group discussions, hands-on workshops, poster presentations, and a strong industry program.
Program Highlights Include:
- Molecular Classification and Pathology Classification
- Surgery and Perioperative Treatment for GEJ Tumors
- CDH1 & gastric cancer genetics
- Immunotherapy
- Robotic & Laparoscopic Surgery
- Hot topics in radiotherapy
- Management of non-adenocarcinoma gastric tumors [FAP adenoma, Carcinioid, GIST]
- Supportive & Palliative care
- Artificial Intelligence in the Management of Gastric Cancer
- and others!
IGCC 2022 aims to bring together a network of gastric cancer professionals and representatives to educate healthcare practitioners and advance high-quality patient care around the world.
Keep an eye on our website and channels for updated information on the program, registration, as well as abstract submissions.
We look forward to meeting in Houston!
Dr Paul Mansfield, M.D., F.A.C.S.
IGCC President-Elect
MD Anderson |
Dr Brian D. Badgwell, M.D.
IGCC 2022 Secretary-General
MD Anderson |
IGCC 2022 注册费：
All registration rates will have 8.25% tax charged on top of the rates above.
所有注册费率将在上述费率基础上加收8.25%的税。
Registration Modification & Cancellation-注册变更与取消
For cancellations received prior to Friday 04 February 2022, midnight CET, deposits will be refunded less 25'% administrative charge. After this date, no refunds will be possible.
A handling fee of 40 USD per registration will be charged for every registration modification received from Friday 04 February 2022.
If a badge is lost or forgotten onsite, an administrative fee of 50 USD will be charged for the reprint of the badge after identity verification (passport, driving license or other recognised identification documents).
◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|
